A phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft ‐tissue sarcoma

Cancer Science,Volume 0, Issue ja, -Not available-.

Source: Cancer Science - October 24, 2018 Category: Cancer & Oncology Authors: Kan Yonemori, Makoto Kodaira, Taroh Satoh, Toshihiro Kudo, Shunji Takahashi, Kenji Nakano, Yuichi Ando, Tomoya Shimokata, Joji Mori, Koichi Inoue, Gerard Joseph Oakley, Sachi Sakaguchi, Kenji Tamura Source Type: research